Eagle Pharmaceuticals Inc
OTC:EGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eagle Pharmaceuticals Inc
OTC:EGRX
|
US |
|
L
|
LPN Development PCL
SET:LPN
|
TH |
|
E
|
Erste Group Bank AG
XBSE:EBS
|
AT |
|
D
|
Danone SA
F:BSN
|
FR |
|
A
|
Asian Alliance International PCL
SET:AAI
|
TH |
|
Fortescue Metals Group Ltd
ASX:FMG
|
AU |
|
S
|
Sandisk Corp
SWB:BW9
|
US |
|
First Bancorp (North Carolina)
NASDAQ:FBNC
|
US |
|
Old Mutual Ltd
F:2KS
|
ZA |
|
Asics Corp
F:ASI1
|
JP |
|
Mediaalpha Inc
NYSE:MAX
|
US |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
|
Plato Gold Corp
XTSX:PGC
|
CA |
|
Sands China Ltd
F:599A
|
MO |
|
Secom Co Ltd
F:XSC
|
JP |
|
EchoIQ Ltd
ASX:EIQ
|
AU |
|
CVB Financial Corp
NASDAQ:CVBF
|
US |
|
FVCBankcorp Inc
NASDAQ:FVCB
|
US |
|
Standard Bank Group Ltd
OTC:SGBLY
|
ZA |
|
E
|
Equity LifeStyle Properties Inc
F:MHV
|
US |
|
T
|
Teamway International Group Holdings Ltd
HKEX:1239
|
HK |
|
D
|
Dentsu Group Inc
OTC:DNTUF
|
JP |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
US |
|
Konica Minolta Inc
TSE:4902
|
JP |
Bankruptcy Probability
Eagle Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eagle Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eagle Pharmaceuticals Inc
OTC:EGRX
|
12.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eagle Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eagle Pharmaceuticals Inc has total debt of 61.9m USD. This includes both short-term (0 USD) and long-term (61.9m USD) debt.
You can find a full breakdown on its Balance Sheet.